Research Paper Volume 15, Issue 21 pp 12314—12329

Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification

class="figure-viewer-img"

Figure 3. Clinical correlation and independent prognostic analysis. (A) Association between DLAT and traditional clinical features from TCGA. Blue on the left represents low DLAT expression, while red on the right represents high DLAT expression; and each line represents one clinical feature. (B, C) Univariate and multivariate Cox regression analyses confirmed the independent prognosis value of DLAT. *: P< 0.05; **: P< 0.01; ***: P< 0.001.